Table S5. Relationship between IGSF3 expression and clinicopathologic features (n=49).
| Features | Relative IGSF3 expression | P value | |
|---|---|---|---|
| Low (n=23) | High (n=26) | ||
| Age | 0.2092 | ||
| ≤50 | 4 | 9 | |
| >50 | 19 | 17 | |
| Sex | 0.1944 | ||
| Male | 22 | 21 | |
| Female | 1 | 5 | |
| AFP (μg/L) | 0.5276 | ||
| ≤400 | 15 | 20 | |
| >400 | 8 | 6 | |
| HBV | 0.7471 | ||
| Positive | 7 | 6 | |
| Negative | 16 | 20 | |
| Tumor diameter (cm) | 0.0001 | ||
| ≤5 | 19 | 7 | |
| >5 | 4 | 19 | |
| TNM stage | 0.0002 | ||
| I–II | 18 | 6 | |
| III–IV | 5 | 20 | |
| Vascular invasion | 0.1250 | ||
| Yes | 17 | 24 | |
| No | 6 | 2 | |
| Lymph node metastasis | 0.0045 | ||
| Yes | 0 | 8 | |
| No | 23 | 18 | |
Significance figures are P values for Fisher’s exact test.